Raily Aesthetic Medicine International Holdings Limited EBIT

The latest EBIT for 2135.HK is $-12M as of June 2026. That compares with $-45M in the prior-year period — up 72.8% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Raily Aesthetic Medicine International Holdings Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 2135.HK's EBIT moved from $-45M to $-12M — a 72.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Raily Aesthetic Medicine International Holdings Limited's operating scale or balance-sheet position.

Against its sector companies, 2135.HK currently prints $-12M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Raily Aesthetic Medicine International Holdings Limited's growth, margins, and balance sheet.

A EBIT figure of $-12M for 2135.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 2135.HK's EBIT ($-12M), review year-over-year change from $-45M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.